Form 4: NHC Executive McCreary Reports Stock Vesting, Tax Withholding

Sentiment:

Insider Transaction Report 5 January 2026 5:02 PM

📋All filings for National Healthcare CORP

National Healthcare Corp's Senior VP & General Counsel, Josh A. McCreary, reported the vesting of restricted stock and the withholding of shares for tax obligations.

Summary

Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp (NHC), reported transactions related to his beneficial ownership.
On January 1, 2026, 1,162 shares of restricted common stock vested, which were originally granted on March 8, 2023, March 5, 2024, and March 5, 2025.
The company withheld 496 shares of common stock on November 11, 2025, at a price of $137.9 per share, to cover tax obligations related to the vesting.
Following this transaction, McCreary directly beneficially owns 9,942 shares of common stock.
McCreary also holds options to purchase common stock: 4,000 shares at $53.94 (exercisable 03/08/2024, expiring 03/08/2028), 8,000 shares at $94.1 (exercisable 03/05/2025, expiring 03/05/2029), and 13,500 shares at $90.62 (exercisable 02/24/2026, expiring 02/24/2030).

Sentiment

Score: 6

Explanation: The filing reports a routine executive compensation event involving restricted stock vesting and tax withholding, which is a neutral to slightly positive event as it indicates continued executive alignment with shareholder interests through equity ownership, despite the tax-related disposition.

Positives

The executive continues to hold a significant number of common shares (9,942) and substantial stock options (25,500 shares), aligning his interests with shareholders.
The vesting of restricted stock indicates the fulfillment of long-term incentive compensation plans.

Negatives

496 shares were disposed of to cover tax liabilities, representing a reduction in direct share ownership from the vested amount.

Future Outlook

Industry Context

Stakeholder Impact

Shareholders: The executive's continued equity ownership (9,942 shares and 25,500 options) aligns his interests with shareholders, potentially fostering long-term value creation.
Employees: The vesting of restricted stock is part of an executive compensation package, which can serve as a model for other employees' long-term incentives.

Key Dates

Date	Description
2023-03-08	Original grant date for a portion of the restricted stock that vested.
2024-03-05	Original grant date for a portion of the restricted stock that vested.
2024-03-08	Date when 4,000 stock options became exercisable; expiration date for these options is 03/08/2028.
2025-03-05	Original grant date for a portion of the restricted stock that vested and date when 8,000 stock options became exercisable, with expiration date 03/05/2029.
2025-11-11	Transaction date for the withholding of 496 shares of common stock for tax obligations.
2026-01-01	Date of earliest transaction reported; 1,162 shares of restricted stock vested.
2026-01-05	Signature date of the reporting person for the Form 4 filing.
2026-02-24	Date when 13,500 stock options become exercisable, with expiration date 02/24/2030.

Recommendation

hold

This Form 4 filing details a routine executive compensation event (restricted stock vesting and tax withholding) and the executive's existing option holdings. It does not provide new information that would fundamentally alter the investment thesis for National Healthcare Corp. The transaction is expected and reflects standard compensation practices, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

National Healthcare Corp, NHC, Josh A McCreary, Form 4, insider trading, beneficial ownership, restricted stock, stock options, executive compensation, tax withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.